Humira has been a blockbuster worldwide for nearly two decades. The biologic has multiple indications, including rheumatoid arthritis, Crohn’s disease and psoriasis. The Foundation asserts that ...

Biosimilars show comparable safety with Humira among new users with psoriasis in a multinational cohort study, but ...

Humira has been off-patent for more than a ... One of the newer products has already got off to a good start – psoriasis drug Skyrizi pulled in a respectable $311 million after FDA approval ...

TNF blockers like Humira are a staple of PsA treatment ... first nine months of this year from its approved uses in plaque psoriasis, psoriatic arthritis and ankylosing spondylitis.

This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or commencing any course of treatment ...

Psoriasis is a chronic skin disorder characterized ... Three other biologics — adalimumab (Humira; Abbott), etanercept (Enbrel; Amgen/Wyeth/Takeda) and infliximab (Remicade; Centocor Ortho ...

Children's dosage is also based on weight. If you are using this medication to treat psoriasis, hidradenitis suppurativa, Crohn's disease, ulcerative colitis, or uveitis, your doctor may prescribe ...